title: Nonprofit foundations spur translational research.
abstract: Every year, hundreds of promising basic discoveries in the pharmacological field are lost and will never have a chance to be exploited for patients due to difficulties in clinical translation. This is especially true for most neurodegenerative disorders lacking disease-modifying therapies. Here we present the current scenario and our vision of a 'collective-impact' multistakeholder approach to expedite the development of new drugs.
authors.affiliation: Italian Multiple Sclerosis Foundation, Genoa, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Zaratin
authors.affiliation: Italian Multiple Sclerosis Foundation, Genoa, Italy.
authors.forename: Mario Alberto
authors.initials: MA
authors.lastname: Battaglia
authors.affiliation: Department of Pharmacological and and Biomolecular Sciences, University of Milan, Milan, Italy. Electronic address: mariapia.abbracchio@unimi.it.
authors.forename: Maria P
authors.initials: MP
authors.lastname: Abbracchio
mesh_terms: D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D009939:Organizations, Nonprofit; D010600:Pharmacology / Q000379:methods*; D057170:Translational Research, Biomedical